Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
An employee of French drugmaker Ipsen has agreed to plead guilty to illegally making more than $262,000 by trading on inside information he learned about his company's plans to acquire cancer drug developer Epizyme in 2022. https://t.co/POxqEV4lSx https://t.co/POxqEV4lSx
AbbVie sued rival BeiGene for allegedly stealing its cancer therapy secrets after hiring away a former longtime senior scientist. AbbVie said it was seeking unspecified monetary damages and a court order to 'recover and protect its trade secret' https://t.co/zBujq624zR https://t.co/sazTajetds
Pharmaceutical giant AbbVie has sued cancer treatment maker BeiGene in Chicago federal court, accusing it of stealing trade secrets to develop a competing cancer-fighting therapy after hiring away a former longtime senior AbbVie scientist https://t.co/zBujq624zR https://t.co/tXdJyUEZld
Pharmaceutical giant AbbVie has filed a lawsuit against cancer treatment maker BeiGene in Chicago federal court. The lawsuit accuses BeiGene of stealing trade secrets to develop a competing cancer-fighting therapy after hiring away a former longtime senior AbbVie scientist. AbbVie claims that the stolen trade secrets were used to develop a drug that targets and destroys a molecule present in B cell growth. The company is seeking unspecified monetary damages and a court order to recover and protect its trade secrets.
